|
| 36413976 | Efficacy of Anti-PD1 Blockade in Treating Recurrent or Metastatic Nasopharyngeal Cancer: A Systematic Review and Meta-analysis. | Oral Oncol | 2023 |
| 37862240 | Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types. | JNCI Cancer Spectr | 2023 |
| 37520028 | The impact of the COVID-19 pandemic on nasopharyngeal carcinoma patients - a national cancer centre experience. | Holist Integr Oncol | 2023 |
| 37700560 | Transcriptomic analyses of localized prostate cancers of East Asian and North American men reveal race-specific luminal-basal and microenvironmental differences. | Cancer Commun (Lond) | 2023 |
| 37457823 | Challenges and Opportunities With the Use of Hypofractionated Radiation Therapy in Cancer Care: Regional Perspectives From South Korea, Japan, Singapore, and Australia. | Adv Radiat Oncol | 2023 |
| 37456700 | Assessing the efficacy of palliative radiation treatment schemes for locally advanced squamous cell carcinoma of the head and neck: a meta-analysis. | Rep Pract Oncol Radiother | 2023 |
| 37290469 | Adjuvant chemotherapy in nasopharyngeal carcinoma. | Lancet Oncol | 2023 |
| 37188668 | Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma. | Nat Commun | 2023 |
| 37451682 | Inferring cancer disease response from radiology reports using large language models with data augmentation and prompting. | J Am Med Inform Assoc | 2023 |
| 37285311 | The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer. | J Natl Cancer Inst | 2023 |
| 37270247 | Passing the Kool-Aid Point: mRNA Expression-Based Risk Classifiers in Localized Prostate Cancer Treatment Decision Making. | Int J Radiat Oncol Biol Phys | 2023 |
| 37431969 | Far from the truth: Real-world treatment patterns among newly diagnosed metastatic prostate cancer in the era of treatment intensification. | Int J Urol | 2023 |
| 36723440 | Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions. | J Natl Cancer Inst | 2023 |
| 36812447 | ASCO's Leadership Development Program: Focusing on the Next Generation of Leaders in Asia Pacific. | JCO Glob Oncol | 2023 |
| 36812346 | A phase 2 study of thalidomide for the treatment of radiation-induced blood-brain barrier injury. | Sci Transl Med | 2023 |
| 36809908 | Management of the neck in nasopharyngeal carcinoma-time for a radical change? | Chin Clin Oncol | 2023 |
| 36872457 | Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study. | J Cachexia Sarcopenia Muscle | 2023 |
| 36842441 | Hyperfractionation for reirradiation of recurrent nasopharyngeal carcinoma. | Lancet | 2023 |
| 36672300 | A Review of the Current Clinical Evidence for Loco-Regional Moderate Hyperthermia in the Adjunct Management of Cancers. | Cancers (Basel) | 2023 |
| 36895163 | Patient-reported functional outcomes and oncological control after primary focal cryotherapy for clinically significant prostate cancer: A Phase II mandatory biopsy-monitored study. | Prostate | 2023 |
| 36526401 | Stochastic Stomatitis: Radiation Recall Reactions in the Era of Immune Checkpoint Blockade. | Int J Radiat Oncol Biol Phys | 2023 |
| 32605887 | Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer. | Eur Urol Oncol | 2022 |
| 35378217 | Efficacy and Safety of Apatinib for Radiation-induced Brain Injury Among Patients With Head and Neck Cancer: An Open-Label, Single-Arm, Phase 2 Study. | Int J Radiat Oncol Biol Phys | 2022 |
| 35569469 | A Bit More Here and a Little Less There: The Trials (and Tribulations) of Adjuvant and Neoadjuvant Head and Neck Studies in 2021. | Int J Radiat Oncol Biol Phys | 2022 |
| 35713589 | Financial toxicities of cancer in low- and middle-income countries: Perspectives from Southeast Asia. | Cancer | 2022 |
| 36000794 | Patient-reported outcomes of a phase II neoadjuvant apalutamide (ARN-509) and radical prostatectomy in treatment of intermediate- to high-risk prostate cancer (NEAR) trial. | Int J Urol | 2022 |
| 36065359 | Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis. | Clin Transl Radiat Oncol | 2022 |
| 36034411 | Mortality of early treatment for radiation-induced brain necrosis in head and neck cancer survivors: A multicentre, retrospective, registry-based cohort study. | EClinicalMedicine | 2022 |
| 36227615 | Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Clinical Trial. | JAMA Oncol | 2022 |
| 35954343 | Germline Variants Associated with Nasopharyngeal Carcinoma Predisposition Identified through Whole-Exome Sequencing. | Cancers (Basel) | 2022 |
| 35288663 | Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer. | Prostate Cancer Prostatic Dis | 2022 |
| 35131810 | Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis. | BMJ Open | 2022 |
| 34919876 | In Reply to Abbasi et al. | Int J Radiat Oncol Biol Phys | 2022 |
| 35287756 | Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational study. | Cardiooncology | 2022 |
| 35129873 | Adolescents and young adults with cancer: Considerations from the Southeast Asian perspective. | Pediatr Blood Cancer | 2022 |
| 34918497 | JUPITER-02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps. | Cancer Commun (Lond) | 2022 |
| 35091711 | NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer. | Prostate Cancer Prostatic Dis | 2022 |
| 34908240 | Efficacy, toxicity, and quality-of-life outcomes of ultrahypofractionated radiotherapy in patients with localized prostate cancer: A single-arm phase 2 trial from Asia. | Asia Pac J Clin Oncol | 2022 |
| 35213233 | Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: <i>Quo Vadis</i>? | J Clin Oncol | 2022 |
| 34971660 | Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial. | Radiother Oncol | 2022 |
| 35175303 | Maintenance Capecitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma-Magic Bullet or Pandora's Box? | JAMA Oncol | 2022 |
| 35134266 | Managing advanced prostate cancer in the Asia Pacific region: "Real-world" application of Advanced Prostate Cancer Consensus Conference 2019 statements. | Asia Pac J Clin Oncol | 2022 |
| 34580764 | Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures. | Cancer Immunol Immunother | 2022 |
| 34538726 | Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy. | Urol Oncol | 2022 |
| 34677648 | Correction to: Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures. | Cancer Immunol Immunother | 2022 |
| 33410867 | Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19. | JAMA Oncol | 2021 |
| 33571626 | International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma. | Int J Radiat Oncol Biol Phys | 2021 |
| 33516431 | Immunotherapy in Head and Neck Cancer-Ready for Prime Time or More Research Needed? | Int J Radiat Oncol Biol Phys | 2021 |
| 33610004 | Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study. | Oral Oncol | 2021 |
| 33498092 | Reply to Colorectal cancer and COVID-19: Do we need to raise awareness and vigilance? | Cancer | 2021 |